BIOLIFE SOLUTIONS INC - Common Stock (BLFS) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
BLFS on Nasdaq
Shares outstanding
47,953,549
Price per share
$22.58
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
48,929,488
Total reported value
$1,183,329,320
% of total 13F portfolios
0%
Share change
+530,942
Value change
+$11,930,683
Number of holders
184
Price from insider filings
$22.58
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIOLIFE SOLUTIONS INC - Common Stock (BLFS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Casdin Capital, LLC 12% -11% $151,967,279 -$19,132,500 5,957,165 -11% Casdin Capital, LLC 15 Oct 2025
T. Rowe Price Investment Management, Inc. 11% +21% $125,272,324 +$22,586,973 5,180,824 +22% T. Rowe Price Investment Management, Inc. 31 Dec 2025
Invesco Ltd. 8.2% $93,979,365 3,932,191 Invesco Ltd. 31 Dec 2025

As of 31 Dec 2025, 184 institutional investors reported holding 48,929,488 shares of BIOLIFE SOLUTIONS INC - Common Stock (BLFS). This represents 102% of the company’s total 47,953,549 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BIOLIFE SOLUTIONS INC - Common Stock (BLFS) together control 83% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Casdin Capital, LLC 12% 5,957,165 -11% 8.9% $144,044,250
BlackRock, Inc. 12% 5,911,614 +5.6% 0% $142,942,826
T. Rowe Price Investment Management, Inc. 11% 5,180,824 +27% 0.08% $125,273,000
Invesco Ltd. 8.2% 3,932,191 +9.2% 0.01% $95,080,378
VANGUARD GROUP INC 6.4% 3,087,386 +4% 0% $74,652,994
FMR LLC 3.2% 1,548,194 +52% 0% $37,435,325
STATE STREET CORP 3.1% 1,505,593 +3.4% 0% $36,405,239
FRED ALGER MANAGEMENT, LLC 2.3% 1,083,838 -2.3% 0.1% $26,207,203
DIMENSIONAL FUND ADVISORS LP 2.1% 1,025,170 +2.2% 0.01% $24,790,513
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.1% 1,004,164 -8.5% 0.01% $24,280,686
GEODE CAPITAL MANAGEMENT, LLC 2% 953,126 +0.08% 0% $23,050,226
AMERIPRISE FINANCIAL INC 1.9% 904,318 -0.5% 0% $21,866,410
ROYAL BANK OF CANADA 1.7% 819,275 -11% 0% $19,812,000
PALISADE CAPITAL MANAGEMENT, LP 1.7% 811,010 -11% 0.58% $19,610,222
GENEVA CAPITAL MANAGEMENT LLC 1.7% 803,538 -11% 0.36% $19,429,537
Rockefeller Capital Management L.P. 1.5% 705,863 -30% 0.04% $17,067,767
Stephens Investment Management Group LLC 1.3% 606,887 -0.32% 0.19% $14,674,528
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 1.2% 575,463 -8.7% 0.15% $13,914,695
MORGAN STANLEY 1.1% 535,040 -7.9% 0% $12,937,288
GAGNON SECURITIES LLC 1.1% 534,357 -0.26% 2.6% $12,920,752
BANK OF AMERICA CORP /DE/ 1.1% 521,327 +9% 0% $12,605,688
VOYA INVESTMENT MANAGEMENT LLC 1% 496,937 -0.06% 0.01% $12,015,936
Granahan Investment Management, LLC 1% 482,356 +23% 0.5% $11,663,368
RAYMOND JAMES FINANCIAL INC 0.92% 440,054 -8.4% 0% $10,826,464
Curi Capital, LLC 0.88% 423,542 -2% 0.18% $10,241,240

Institutional Holders of BIOLIFE SOLUTIONS INC - Common Stock (BLFS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 48,929,488 $1,183,329,320 +$11,930,683 $24.18 184
2025 Q3 48,107,711 $1,227,205,552 -$39,555,573 $25.51 188
2025 Q2 49,891,551 $1,074,666,783 +$46,085,035 $21.54 193
2025 Q1 47,668,681 $1,088,709,499 +$20,128,588 $22.84 188
2024 Q4 46,805,050 $1,214,970,700 +$32,660,204 $25.96 179
2024 Q3 45,256,383 $1,133,546,998 -$37,704,401 $25.04 193
2024 Q2 46,759,086 $1,001,701,609 +$52,199,509 $21.43 164
2024 Q1 44,406,426 $823,506,297 -$18,755,552 $18.55 148
2023 Q4 45,388,256 $737,705,671 +$37,803,026 $16.25 138
2023 Q3 43,572,418 $601,804,361 +$31,718,369 $13.81 152
2023 Q2 40,574,468 $896,734,819 +$40,556,636 $22.10 155
2023 Q1 38,757,969 $842,823,822 +$17,191,226 $21.75 165
2022 Q4 38,161,776 $694,539,798 -$10,679,652 $18.20 160
2022 Q3 38,421,067 $874,137,954 +$38,798,900 $22.75 169
2022 Q2 36,797,091 $508,323,451 +$12,324,863 $13.81 146
2022 Q1 35,131,386 $798,491,817 -$7,596,956 $22.73 155
2021 Q4 34,958,126 $1,302,914,183 +$115,722,970 $37.27 165
2021 Q3 31,670,115 $1,340,574,104 +$157,430,709 $42.32 159
2021 Q2 27,974,612 $1,245,139,856 +$121,193,958 $44.51 130
2021 Q1 25,413,123 $914,855,472 +$45,084,655 $36.00 130
2020 Q4 24,231,900 $966,664,009 +$97,438,296 $39.89 125
2020 Q3 22,145,073 $640,866,936 +$216,554,424 $28.94 104
2020 Q2 14,927,170 $244,144,153 +$49,280,131 $16.35 82
2020 Q1 12,125,864 $115,194,176 +$10,152,917 $9.50 73
2019 Q4 10,352,922 $167,504,873 -$1,157,792 $16.18 79
2019 Q3 10,248,020 $170,376,845 +$21,192,749 $16.63 78
2019 Q2 8,980,039 $150,448,121 +$6,076,613 $16.95 71
2019 Q1 8,599,553 $153,847,483 +$19,590,648 $17.89 65
2018 Q4 7,525,099 $90,520,000 -$6,348,673 $12.03 52
2018 Q3 7,614,985 $133,259,000 +$55,383,982 $17.50 51
2018 Q2 4,545,796 $51,865,700 +$32,049,888 $11.41 45
2018 Q1 1,683,075 $8,619,000 -$151,371 $5.12 23
2017 Q4 1,709,367 $10,256,000 +$2,569,633 $6.00 26
2017 Q3 1,282,103 $7,324,000 +$5,380,776 $5.71 19
2017 Q2 339,958 $813,000 +$183,536 $2.40 8
2017 Q1 266,914 $557,000 +$91,186 $2.09 8
2016 Q4 266,829 $431,000 -$33,995 $1.60 11
2016 Q3 282,237 $518,000 -$124,588 $1.84 10
2016 Q2 381,436 $609,000 +$39,267 $1.60 9
2016 Q1 356,480 $653,000 +$28,574 $1.83 9
2015 Q4 338,498 $736,000 +$10,054 $2.20 7
2015 Q3 333,970 $707,000 +$93,511 $2.12 6
2015 Q2 290,217 $566,010 -$196,456 $1.95 5
2015 Q1 422,277 $681,008 -$329,999 $1.61 9
2014 Q4 623,246 $1,023,008 -$91,795 $1.64 7
2014 Q3 579,026 $1,216,311 +$668 $2.10 7
2014 Q2 577,808 $1,318,011 +$1,318,011 $2.28 8